Chimin Health Management Management

Management Kriterienprüfungen 2/4

Wir verfügen derzeit nicht über ausreichende Informationen über den CEO.

Wichtige Informationen

Yunfei Tian

Geschäftsführender

CN¥938.0k

Gesamtvergütung

Prozentsatz des Geschäftsführergehalts	n/a
Amtszeit als Geschäftsführer	11.2yrs
Eigentum des Geschäftsführers	0.7%
Durchschnittliche Amtszeit des Managements	keine Daten
Durchschnittliche Amtszeit der Vorstandsmitglieder	6.3yrs

Jüngste Management Updates

Recent updates

Subdued Growth No Barrier To Chimin Health Management Co., Ltd. (SHSE:603222) With Shares Advancing 25%

Nov 11

More Unpleasant Surprises Could Be In Store For Chimin Health Management Co., Ltd.'s (SHSE:603222) Shares After Tumbling 31%

Jun 09

Geschäftsführer

Yunfei Tian (42 yo)

11.2yrs

Amtszeit

CN¥938,000

Vergütung

Mr. Yunfei Tian serves as President of Chimin Health Management Co., Ltd. (formerly known as Zhejiang Chimin Pharmaceutical CO.,Ltd) and also serves as its Director since September 22, 2013. Mr. Tian serve...

Vorstandsmitglieder

Name	Position	Amtszeit	Vergütung	Eigentümerschaft
Yunfei Tian	President & Director	11.2yrs	CN¥938.00k	0.68% CN¥ 27.7m
Gao Peng Qiu	Executive VP & Director	11.2yrs	CN¥693.90k	keine Daten
Kun Chen	Director	no data	CN¥900.00k	keine Daten
Lisha Li	Chairman	8.1yrs	CN¥823.60k	2.67% CN¥ 108.8m
Yongquan Li	Independent Director	2yrs	CN¥75.00k	keine Daten
Lian Lan Wang	Supervisor	2yrs	keine Daten	keine Daten
Li Zhi Jin	Independent Director	6.3yrs	CN¥75.00k	keine Daten
Kaitian Wang	Independent Director	5.1yrs	CN¥75.00k	keine Daten

6.3yrs

Durchschnittliche Betriebszugehörigkeit

47.5yo

Durchschnittliches Alter

Erfahrener Vorstand: 603222Die Vorstandsmitglieder gelten als erfahren (6.3 Jahre durchschnittliche Amtszeit).

Chimin Health Management Management

Management Kriterienprüfungen 2/4

Wichtige Informationen

Jüngste Management Updates

Chimin Health Management Co., Ltd., Annual General Meeting, May 29, 2024

Less than half of directors are independent

Less than half of directors are independent

Recent updates

Subdued Growth No Barrier To Chimin Health Management Co., Ltd. (SHSE:603222) With Shares Advancing 25%

Third quarter 2024 earnings released: EPS: CN¥0.005 (vs CN¥0.01 in 3Q 2023)

Chimin Health Management Co., Ltd. to Report Q3, 2024 Results on Oct 30, 2024

New minor risk - Share price stability

Second quarter 2024 earnings released: EPS: CN¥0.02 (vs CN¥0.01 in 2Q 2023)

Chimin Health Management Co., Ltd. to Report First Half, 2024 Results on Aug 29, 2024

More Unpleasant Surprises Could Be In Store For Chimin Health Management Co., Ltd.'s (SHSE:603222) Shares After Tumbling 31%

Chimin Health Management Co., Ltd., Annual General Meeting, May 29, 2024

First quarter 2024 earnings released: EPS: CN¥0.03 (vs CN¥0.06 in 1Q 2023)

Chimin Health Management Co., Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Chimin Health Management Co., Ltd. to Report Fiscal Year 2023 Results on Apr 26, 2024

Third quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.033 in 3Q 2022)

New minor risk - Earnings quality

Chimin Health Management Co., Ltd. (SHSE:603222) announces an Equity Buyback for CNY 120 million worth of its shares.

Second quarter 2023 earnings released: EPS: CN¥0.01 (vs CN¥0.013 loss in 2Q 2022)

Chimin Health Management Co., Ltd. to Report First Half, 2023 Results on Aug 30, 2023

Full year 2022 earnings released: EPS: CN¥0.07 (vs CN¥0.31 in FY 2021)

Now 21% undervalued

Investor sentiment improves as stock rises 15%

Investor sentiment improved over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Third quarter 2022 earnings released: EPS: CN¥0.033 (vs CN¥0.08 in 3Q 2021)

Second quarter 2022 earnings released: CN¥0.013 loss per share (vs CN¥0.14 profit in 2Q 2021)

Investor sentiment improved over the past week

First quarter 2022 earnings released: EPS: CN¥0.21 (vs CN¥0.12 in 1Q 2021)

Less than half of directors are independent

Now 21% undervalued

Investor sentiment improved over the past week

Chimin Health Management Co., Ltd. announced that it expects to receive CNY 900 million in funding

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS CN¥0.11 (vs CN¥0.099 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.20 (vs CN¥0.041 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.12 (vs CN¥0.02 loss in 1Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥9.74

New 90-day low: CN¥10.51

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

New 90-day low: CN¥30.47

New 90-day high: CN¥39.00

Chimin Health Management Co., Ltd. to Report Q3, 2020 Results on Oct 30, 2020

Third quarter earnings released

New 90-day high: CN¥37.29

First half earnings released

First half earnings released

New 90-day low - CN¥34.20

Chimin Health Management Co., Ltd. to Report First Half, 2020 Results on Aug 28, 2020

Geschäftsführer

Amtszeit

Vergütung

Vorstandsmitglieder

Durchschnittliche Betriebszugehörigkeit

Durchschnittliches Alter